- Coordinator
- Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV, Germany
- Runs
- 1 March 2023 to 30 November 2027
- Status
- Running
- EU funding
- €3.0m
- Total cost
- €3.0m
- Partners
- 8 organisations in 5 countries
- Type
- European Innovation Council
- Grant agreement
- 101099210
What the project is doing
In the project's own words, from its summary on CORDIS.
The overall goal of this project is to develop a radically new diagnostic and therapeutic device for neurological applications which combines a highly innovative ultrasound component for brain imaging and focused stimulation of brain regions with advanced electrophysiological measurements of neural activity. First goal of the project is the development of a novel ultrasound (US)-based functional imaging method that, in conjunction with electroencephalography (EEG), allows for high spatiotemporal resolution examination of brain activity.
While EEG itself yields best data from neural tissue close to the skull, the US component is designed to deliver images from deeper brain regions. The second pillar of the device’s function is focused US brain stimulation. Based on the possibility to localize abnormal activity, the neuromodulation component of the novel device can be guided to focal stimulation of selected brain regions, which can be further developed into a closed-loop design.
The full envisioned system is a versatile tool that combines EEG-sensors and US transceivers in a wearable headset. The project foresees the development of hard- and software as well as algorithms to integrate the information from both modalities into functional neuroimaging with unpreceded spatiotemporal resolution. Beyond the technical realization, this project includes a proof of concept study to evaluate and demonstrate practical applicability in healthy participants and in patients with epilepsy, during clinical routine examination, cognitive, and sensory stimulation, including test-retest validation.
The new device will reduce the time to examine and treat neurological patients and the cost thereof. The ability to perform better diagnosis via accurate imaging, targeted neurostimulation, and neuromodulation with a cost-effective, non-invasive device will have transformative effects on treatment options for neurological diseases and stimulate new lines of research in cognitive neuroscience
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Coordinator |
| G.tec Medical Engineering GmbH | Schiedlberg | Austria | Participant |
| Gemeinnutzige Salzburger Landeskliniken Betriebsgesellschaft | Salzburg | Austria | Participant |
| Mediri GmbH | Heidelberg | Germany | Participant |
| Haskolinn a Akureyri | Akureyri | Iceland | Participant |
| Universita Degli Studi Di Roma La Sapienza | Roma | Italy | Participant |
| Universita Degli Studi Di Roma Tor Vergata | Roma | Italy | Associatedpartner |
| Percuros BV | 's-Gravenhage (Den Haag) | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI